Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications (Q37988754)

26 August 2017

Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications (English)

1 reference

26 August 2017

mesenchymal stem cell

1 reference

Tacghee Yi

1

1 reference

PubMed ID

22370776

26 August 2017

Sun U Song

series ordinal

2

1 reference

26 August 2017

28 February 2012

1 reference

Archives of Pharmacal Research

26 August 2017

1 reference

26 August 2017

35

1 reference

26 August 2017

2

1 reference

26 August 2017

213-221

1 reference

https://scigraph.springernature.com/pub.10.1007/s12272-012-0202-z

26 August 2017

0 references

cites work

Human mesenchymal stem cells modulate allogeneic immune cell responses

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Mesenchymal stromal cells: facilitators of successful transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Identification and enrichment of human osteoprogenitor cells by using differentiation stage-specific monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Marrow stromal cells as stem cells for nonhematopoietic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Variations of clonal marrow stem cell lines established from human bone marrow in surface epitopes, differentiation potential, gene expression, and cytokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Interactions between human mesenchymal stem cells and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Cartilage disorders: potential therapeutic use of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Differentiation of human bone marrow mesenchymal stem cells into bladder cells: potential for urological tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Concise review: hitting the right spot with mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Mesenchymal stem cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-012-0202-Z

10.1007/S12272-012-0202-Z

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22370776